Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-07-001877
Filing Date
2007-10-05
Accepted
2007-10-05 13:15:08
Documents
9
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 URIGEN FORM 10K form10k.htm 10-K 2000848
2 EXHIBIT 21.1 ex211.htm EX-21.1 3946
3 EXHIBIT 23.1 ex231.htm EX-23.1 6686
4 EXHIBIT 23.2 ex232.htm EX-23.2 6467
5 EXHIBIT 3.5 ex35.htm EX-3.5 30141
6 EXHIBIT 31.1 ex311.htm EX-31.1 12499
7 EXHIBIT 31.2 ex312.htm EX-31.2 12193
8 EXHIBIT 32.1 ex321.htm EX-32.1 7699
9 EXHIBIT 32.2 ex322.htm EX-32.2 8248
  Complete submission text file 0001013762-07-001877.txt   2090359
Mailing Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010
Business Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010 (650) 697-1900
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-22987 | Film No.: 071158672
SIC: 2836 Biological Products, (No Diagnostic Substances)